Английская Википедия:18-Methylaminocoronaridine
Материал из Онлайн справочника
Шаблон:Short description Шаблон:Drugbox
(–)-18-Methylaminocoronaridine (18-MAC) is a second generation synthetic derivative of ibogaine developed by the research team led by the pharmacologist Stanley D. Glick from the Albany Medical College and the chemist Martin E. Kuehne from the University of Vermont.[1][2]
See also
- 2-Methoxyethyl-18-methoxycoronaridinate
- 18-Methoxycoronaridine
- Coronaridine
- Ibogaine
- Noribogaine
- Voacangine
References
Шаблон:Nicotinic acetylcholine receptor modulators